You are viewing the site in preview mode

Skip to main content

Table 2 Comparison of imaging features of HCCs in LI-RADS: Gadoxetic acid and gadopentetate dimeglumine

From: Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)

Major HCC features Gadoxetic acid gadopentetate dimeglumine P value
Capsule appearance 3.4(5/145) 5.5(8/145) 0.793
Arterial hyperenhancement 89(129/145) 89(129/145) 1.000
  1. Data are percentages (numbers used to calculate percentages. Data werer compared using the Wilcoxon test. Significant value, P < 0.05
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us